Pharma Stability: Insights, Guidelines, and Expertise
Forced degradation involves exposing pharmaceutical products to extreme physical or chemical stress conditions to induce degradation. Unlike real-time or accelerated stability studies, stress testing pushes products beyond label storage to simulate long-term effects in a short time.
Click to read the full article.
Incorrect or unsubstantiated shelf life decisions can lead to product recalls, failed regulatory inspections, and patient safety concerns. Training ensures that cross-functional teams:
Click to read the full article.
A storage excursion refers to any instance when a pharmaceutical product is exposed to environmental conditions—especially temperature and relative humidity (RH)—outside the defined label storage range.
Click to read the full article.
Multiple sites mean multiple points of risk. Without a standardized approach, shelf life monitoring becomes vulnerable to inconsistencies in:
Click to read the full article.
Pharmaceutical products are sensitive to environmental variables, especially temperature and humidity. Inconsistencies in these parameters may result in:
Click to read the full article.
Stability studies often uncover chemical, physical, or microbiological degradation that could have been mitigated by smart formulation decisions. Common degradation mechanisms include:
Click to read the full article.
Shelf life reduction has both regulatory and commercial consequences:
Click to read the full article.
Regulatory submission for shelf life extension may be required in various scenarios:
Click to read the full article.
Before doing anything regulatory, initiate a formal change control within your Quality Management System (QMS).
Click to read the full article.
The labeling update process begins with formal change control:
Click to read the full article.